-1.png?width=320&height=192&name=Add%20a%20subheading%20(12)-1.png)
Congenica awarded European contract to develop NGS analysis workflow in oncology
Congenica awarded a contract to develop standardised NGS workflows in oncology for a group of 7 Central European hospitals by the Medical University Graz
.png?width=320&height=192&name=Webinar%20the%20cost%20of%20rare%20disease%20(2).png)
The Real Costs of Rare Disease
Congenica welcomed an expert panel to discuss the true cost of rare disease, from birth to diagnosis, childhood to adulthood.
.png?width=320&height=192&name=Untitled%20design%20(60).png)
Congenica and FDB collaborate to incorporate PGx into Clinical Decision Support Systems
Congenica and FDB announce a collaboration agreement to develop the delivery of pharmacogenomics (PGx) results into point of care prescribing.
.png?width=320&height=192&name=Patient%20stories%20(2).png)
Genomics in South Africa
A personal view of Genomics in South Africa by Diane May, mother to Matthew who has been diagnosed with Morquio syndrome.
.png?width=320&height=192&name=Congenica%20employees%20receive%20%E2%80%98cost%20of%20living%E2%80%99%20bonus%20(1).png)
Congenica gives employees ‘cost of living’ bonus
Congenica employees receive one off bonus to help with increases in cost of living
Pharmacogenomics: Personalised psychotropic prescribing in adults with intellectual disabilities
Pharmacogenomics: An opportunity for personalised psychotropic prescribing in adults with intellectual disabilities
.png?width=320&height=192&name=Untitled%20design%20(55).png)
Congenica announces partnership with Avesthagen
Congenica announces a partnership with Avesthagen, strengthenening Congenica’s presence in India
Living with a rare disease in India
As part of our series looking at rare diseases around the world, guest blogger Swapna Roopesh discusses living with a rare disease in India.
.png?width=320&height=192&name=Reality%20Check%20of%20a%2013th%20Birthday%20for%20a%20Caregiver%20(1).png)
Collaborative development of novel Precision Oncology Solution
Congenica has selected the GenomOncology Precision Oncology Platform for the development of a novel ground-breaking CE-IVD Precision Oncology Solution.
Reality Check of a 13th Birthday for a Caregiver
As part of our mental health initiative, Nicole Duaz talks about being mother to Summer, who has a rare genetic disease and autism, and a self-care coach.
%20(1200%20%C3%97%20644%20px).png?width=320&height=192&name=Having%20a%20rare%20disease%20in%20a%20family%20is%20itself%20a%20health%20inequality%20(1920%20%C3%97%201080%20px)%20(1200%20%C3%97%20644%20px).png)
Mental health in the rare disease community
Congenica and partners respond to the UK Government’s open consultation to support mental health and wellbeing
.png?width=320&height=192&name=Congenica%20appoints%20Robert%20Denison%20as%20CEO%20LinkedIn%20(1200%20%C3%97%20675%20px).png)
Congenica appoints Robert Denison as CEO
Congenica announces the appointment of Robert Denison as Chief Executive Officer (CEO). He will also join the Board of the company.